Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer
In this case, multiple immune responses to insulin, including immediate allergy, delayed cutaneous hypersensitivity, and immunologie insulin resistance, were thought to have occurred as a paraneoplastic syndrome based on IL-6 secretion by lung cancer because chemotherapy resulted in a decrease of tu...
Gespeichert in:
Veröffentlicht in: | Diabetes care 2006-07, Vol.29 (7), p.1711-1712 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1712 |
---|---|
container_issue | 7 |
container_start_page | 1711 |
container_title | Diabetes care |
container_volume | 29 |
creator | Mizuhashi, Satomi Nakamura, Keigo Mori, Yasumichi Noda, Mitsuhiko Nakanishi, Koji |
description | In this case, multiple immune responses to insulin, including immediate allergy, delayed cutaneous hypersensitivity, and immunologie insulin resistance, were thought to have occurred as a paraneoplastic syndrome based on IL-6 secretion by lung cancer because chemotherapy resulted in a decrease of tumor size, a decline of plasma IL-6, and a reduction of insulin antibodies. |
doi_str_mv | 10.2337/dc06-0677 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_223029935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A148625370</galeid><sourcerecordid>A148625370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-f30683c793f37c2e0812f1b3f294e004d8b8055ab2719b044e4cb43a36cdbeca3</originalsourceid><addsrcrecordid>eNptkUtLAzEUhYMotlYX_gEJ7lxMzWMeybIUH4WCG10PmcydaWomU5MZpP_elBbclCwCOd-5jxyE7imZM86L51qTPCF5UVygKZU8S7IsFZdoSmgqk0xKNkE3IWwJIWkqxDWa0FwQmlMyRZuVC6M1Ditrwbd7rFyNTdeNrrd9azQ2J91DMGFQTgPWagxQ42ofxQG8hfHbuCTHhyp4pwYDbsC_ZthgO7o24tHkb9FVo2yAu9M9Q1-vL5_L92T98bZaLtaJ5pIOScNJLrguJG94oRkQQVlDK94wmUKcvxaVIFmmKlZQWcV9INVVyhXPdV2BVnyGHo91d77_GSEM5bYfvYstS8Y4YTL-T4SSI9QqC6VxTT94pVtw4JXtHTQmPi9oKnKW8YJEfn6Gj6eGzuizhqejQfs-BA9NufOmU35fUlIeMisPmZWHzCL7cJp4rDqo_8lTSPwPGvWRFw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223029935</pqid></control><display><type>article</type><title>Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mizuhashi, Satomi ; Nakamura, Keigo ; Mori, Yasumichi ; Noda, Mitsuhiko ; Nakanishi, Koji</creator><creatorcontrib>Mizuhashi, Satomi ; Nakamura, Keigo ; Mori, Yasumichi ; Noda, Mitsuhiko ; Nakanishi, Koji</creatorcontrib><description>In this case, multiple immune responses to insulin, including immediate allergy, delayed cutaneous hypersensitivity, and immunologie insulin resistance, were thought to have occurred as a paraneoplastic syndrome based on IL-6 secretion by lung cancer because chemotherapy resulted in a decrease of tumor size, a decline of plasma IL-6, and a reduction of insulin antibodies.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc06-0677</identifier><identifier>PMID: 16801610</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>United States: American Diabetes Association</publisher><subject>Adenocarcinoma - immunology ; Analysis ; Chemotherapy ; Cytokines ; Diabetes ; Diabetes Mellitus, Type 2 - complications ; Drug Eruptions - immunology ; Drug resistance ; Humans ; Immune system ; Insulin ; Insulin - immunology ; Insulin resistance ; Insulin Resistance - immunology ; Lung cancer ; Lung Neoplasms - immunology ; Male ; Middle Aged ; Paraneoplastic Syndromes - immunology ; Plasma ; Risk factors ; Type 2 diabetes</subject><ispartof>Diabetes care, 2006-07, Vol.29 (7), p.1711-1712</ispartof><rights>COPYRIGHT 2006 American Diabetes Association</rights><rights>Copyright American Diabetes Association Jul 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-f30683c793f37c2e0812f1b3f294e004d8b8055ab2719b044e4cb43a36cdbeca3</citedby><cites>FETCH-LOGICAL-c391t-f30683c793f37c2e0812f1b3f294e004d8b8055ab2719b044e4cb43a36cdbeca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16801610$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mizuhashi, Satomi</creatorcontrib><creatorcontrib>Nakamura, Keigo</creatorcontrib><creatorcontrib>Mori, Yasumichi</creatorcontrib><creatorcontrib>Noda, Mitsuhiko</creatorcontrib><creatorcontrib>Nakanishi, Koji</creatorcontrib><title>Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>In this case, multiple immune responses to insulin, including immediate allergy, delayed cutaneous hypersensitivity, and immunologie insulin resistance, were thought to have occurred as a paraneoplastic syndrome based on IL-6 secretion by lung cancer because chemotherapy resulted in a decrease of tumor size, a decline of plasma IL-6, and a reduction of insulin antibodies.</description><subject>Adenocarcinoma - immunology</subject><subject>Analysis</subject><subject>Chemotherapy</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Drug Eruptions - immunology</subject><subject>Drug resistance</subject><subject>Humans</subject><subject>Immune system</subject><subject>Insulin</subject><subject>Insulin - immunology</subject><subject>Insulin resistance</subject><subject>Insulin Resistance - immunology</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Paraneoplastic Syndromes - immunology</subject><subject>Plasma</subject><subject>Risk factors</subject><subject>Type 2 diabetes</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkUtLAzEUhYMotlYX_gEJ7lxMzWMeybIUH4WCG10PmcydaWomU5MZpP_elBbclCwCOd-5jxyE7imZM86L51qTPCF5UVygKZU8S7IsFZdoSmgqk0xKNkE3IWwJIWkqxDWa0FwQmlMyRZuVC6M1Ditrwbd7rFyNTdeNrrd9azQ2J91DMGFQTgPWagxQ42ofxQG8hfHbuCTHhyp4pwYDbsC_ZthgO7o24tHkb9FVo2yAu9M9Q1-vL5_L92T98bZaLtaJ5pIOScNJLrguJG94oRkQQVlDK94wmUKcvxaVIFmmKlZQWcV9INVVyhXPdV2BVnyGHo91d77_GSEM5bYfvYstS8Y4YTL-T4SSI9QqC6VxTT94pVtw4JXtHTQmPi9oKnKW8YJEfn6Gj6eGzuizhqejQfs-BA9NufOmU35fUlIeMisPmZWHzCL7cJp4rDqo_8lTSPwPGvWRFw</recordid><startdate>20060701</startdate><enddate>20060701</enddate><creator>Mizuhashi, Satomi</creator><creator>Nakamura, Keigo</creator><creator>Mori, Yasumichi</creator><creator>Noda, Mitsuhiko</creator><creator>Nakanishi, Koji</creator><general>American Diabetes Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20060701</creationdate><title>Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer</title><author>Mizuhashi, Satomi ; Nakamura, Keigo ; Mori, Yasumichi ; Noda, Mitsuhiko ; Nakanishi, Koji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-f30683c793f37c2e0812f1b3f294e004d8b8055ab2719b044e4cb43a36cdbeca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adenocarcinoma - immunology</topic><topic>Analysis</topic><topic>Chemotherapy</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Drug Eruptions - immunology</topic><topic>Drug resistance</topic><topic>Humans</topic><topic>Immune system</topic><topic>Insulin</topic><topic>Insulin - immunology</topic><topic>Insulin resistance</topic><topic>Insulin Resistance - immunology</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Paraneoplastic Syndromes - immunology</topic><topic>Plasma</topic><topic>Risk factors</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mizuhashi, Satomi</creatorcontrib><creatorcontrib>Nakamura, Keigo</creatorcontrib><creatorcontrib>Mori, Yasumichi</creatorcontrib><creatorcontrib>Noda, Mitsuhiko</creatorcontrib><creatorcontrib>Nakanishi, Koji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mizuhashi, Satomi</au><au>Nakamura, Keigo</au><au>Mori, Yasumichi</au><au>Noda, Mitsuhiko</au><au>Nakanishi, Koji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2006-07-01</date><risdate>2006</risdate><volume>29</volume><issue>7</issue><spage>1711</spage><epage>1712</epage><pages>1711-1712</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>In this case, multiple immune responses to insulin, including immediate allergy, delayed cutaneous hypersensitivity, and immunologie insulin resistance, were thought to have occurred as a paraneoplastic syndrome based on IL-6 secretion by lung cancer because chemotherapy resulted in a decrease of tumor size, a decline of plasma IL-6, and a reduction of insulin antibodies.</abstract><cop>United States</cop><pub>American Diabetes Association</pub><pmid>16801610</pmid><doi>10.2337/dc06-0677</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-5992 |
ispartof | Diabetes care, 2006-07, Vol.29 (7), p.1711-1712 |
issn | 0149-5992 1935-5548 |
language | eng |
recordid | cdi_proquest_journals_223029935 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Adenocarcinoma - immunology Analysis Chemotherapy Cytokines Diabetes Diabetes Mellitus, Type 2 - complications Drug Eruptions - immunology Drug resistance Humans Immune system Insulin Insulin - immunology Insulin resistance Insulin Resistance - immunology Lung cancer Lung Neoplasms - immunology Male Middle Aged Paraneoplastic Syndromes - immunology Plasma Risk factors Type 2 diabetes |
title | Insulin allergy and immunologic insulin resistance caused by interleukin-6 in a patient with lung cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A39%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin%20allergy%20and%20immunologic%20insulin%20resistance%20caused%20by%20interleukin-6%20in%20a%20patient%20with%20lung%20cancer&rft.jtitle=Diabetes%20care&rft.au=Mizuhashi,%20Satomi&rft.date=2006-07-01&rft.volume=29&rft.issue=7&rft.spage=1711&rft.epage=1712&rft.pages=1711-1712&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/dc06-0677&rft_dat=%3Cgale_proqu%3EA148625370%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223029935&rft_id=info:pmid/16801610&rft_galeid=A148625370&rfr_iscdi=true |